Percutaneous Coronary Intervention Followed by Antiplatelet Monotherapy in the Setting of Acute Coronary Syndromes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3410 participants.
Also called NCT04360720
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 3,410 participants
- Registry
-
NCT04360720
-
- Other papers using this trial's data
- Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes
- P2Y12 inhibitor monotherapy versus dual antiplatelet therapy after complex percutaneous coronary intervention in patients with acute coronary syndromes: a NEO-MINDSET trial substudy
- Potent P2Y12 Inhibitor Monotherapy vs DAPT After PCI in Patients With and Without STEMI: The NEO-MINDSET Substudy
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Brazil
- Registry status
- Completed
Technical summary
Registry record NCT04360720. Randomized; single masking; primary purpose treatment. Start 2020-10-15 (actual); primary completion 2024-11-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Percutaneous Coronary Intervention Followed by Antiplatelet Monotherapy in the Setting of Acute Coronary Syndromes
- Acronym
- NEOMINDSET
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Antiplatelet Monotherapy
- Lead sponsor
- Hospital Israelita Albert Einstein
Record details
- Record id
cardio:ct-nct04360720- Content hash
d4ccde29c61c877fe34734da40bac5486e18e39250f1d888a7f953c362c29b09